Meeder Advisory Services’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$368K Buy
+4,277
New +$375K 0.01% 499
2025
Q2
– Sell
-2,755
Closed -$312K – 645
2025
Q1
$312K Sell
2,755
-275
-9% -$29.4K 0.02% 449
2024
Q4
$320K Buy
3,030
+910
+43% +$97.6K 0.02% 434
2024
Q3
$229K Sell
2,120
-262
-11% -$28.6K 0.01% 495
2024
Q2
$259K Buy
2,382
+489
+26% +$57.6K 0.02% 435
2024
Q1
$250K Buy
1,893
+6
+0.3% +$749 0.03% 388
2023
Q4
$230K Buy
+1,887
New +$211K 0.03% 389
2023
Q3
– Sell
-2,170
Closed -$316K – 450
2023
Q2
$316K Sell
2,170
-4
-0.2% -$544 0.03% 354
2023
Q1
$281K Buy
2,174
+98
+5% +$12.3K 0.03% 373
2022
Q4
$265K Buy
+2,076
New +$241K 0.03% 354

Other funds holding ZBH

Meeder Advisory Services's ZBH Position: Q2 2026 in Review

Meeder Advisory Services opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 4,277 shares worth $368K. The stake represents 0.01% of the portfolio and ranks #499 among its holdings. This is a return to the name: Meeder Advisory Services previously reported a position in ZBH as recently as Q1 2025.

Meeder Advisory Services first reported a position in ZBH in Q4 2022 and has held it in 10 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Meeder Advisory Services held 4,277 shares of Zimmer Biomet worth $368K as of Q2 2026.
  • Zimmer Biomet was a new Meeder Advisory Services position in Q2 2026.
  • Zimmer Biomet made up 0.01% of Meeder Advisory Services's portfolio in Q2 2026, its #499 holding.
  • Meeder Advisory Services first reported a position in Zimmer Biomet in Q4 2022 and has held it in 10 quarters since.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.